Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
1380 Predicted and Measured Pagibaximab Serum Levels in High-Risk Neonates
Pagibaximab, a monoclonal antibody for prevention of staphylococcal sepsis in VLBW infants reported no staphylococcal sepsis when serum levels were ≥500ug/ml. Prior to phase 3 studies, we sought to develop a d...